Company: LRHC
Filing Date: 2025-09-25
Form Type: S-1
Source: 0001213900-25-091637
Chunk: 29

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-25
Form: S-1
Chunk 29
---
.

Risks Related to this Offering

The sale of the shares of common stock acquired by the Selling Stockholder, or the perception that such sales may occur, could cause the price of our common stock to decrease.

On September 18, 2025, we entered into the Amended
Facility Agreement with the Selling Stockholder, pursuant to which the Selling Stockholder committed to purchase up to $1,000,000,000
of our common stock. The shares that we may issue and sell to the Selling Stockholder under the Facility may be sold by us to the Selling
Stockholder from time to time at our discretion over a 36-month period commencing on August 5, 2025. The purchase price for the shares
that we may issue and sell to the Selling Stockholder under the Facility will vary based on the price of our common stock at the time
we initiate the sale. Depending on market liquidity at the time, sales of such shares may cause the trading price of our common stock
to decrease.

We generally have the right to control the timing
and amount of any future sales of our shares to the Selling Stockholder. Sales of shares of our common stock to the Selling Stockholder
under the Facility, if any, will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell
to the Selling Stockholder all, some or none of the shares of our common stock that may be available for us to sell pursuant to the Facility.
If and when we do sell shares to the Selling Stockholder, after the Selling Stockholder has acquired the shares, the Selling Stockholder
may resell all, some or none of those shares at any time or from time to time in its discretion. Therefore, sales to the Selling Stockholder
by us could result in substantial dilution to the interests of other holders of our common stock. Additionally, the sale of a substantial
number of shares of our common stock to the Selling Stockholder, or the anticipation of such sales, could make it more difficult for us
to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.

Sales of a substantial number of our securities in the public market by the Selling Stockholder and/or by our existing securityholders could cause the price of our shares of common stock to fall.

The Selling Stockholder can sell, under this Prospectus,
up to 283,333,333 shares of common stock. Sales of a